Physician profile
Adam R Cloud
NPI 1194989582
$683.99
in general payments reported to CMS, 2019-2025
11 companies · $379 in 2025
The $379 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.57 · 2020: $151 · 2021: $44.35 · 2024: $51.82 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $431.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $251.99 | 2020-2025 | Clareon, Argos |
| Johnson & Johnson Vision Care, INC. | $89.98 | 2025 | Acuvue |
| Rayner Intraocular Lenses Limited | $74.19 | 2025 | Omidria, Rayner Cataract Set 1, Rayone Spheric |
| Harrow Eye, LLC | $52.77 | 2025 | Vevye, Iheezo |
| Johnson & Johnson Surgical Vision, INC. | $45.80 | 2025 | Tecnis Simplicity |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $43.00 | 2019-2021 | |
| Eyevance Pharmaceuticals LLC | $42.18 | 2019-2021 | |
| Allergan, INC. | $32.59 | 2020-2021 | |
| Astellas Pharma US INC | $20.02 | 2025 | Izervay |
| Abbvie INC. | $16.46 | 2024 | |
| Biotissue Holdings INC. | $15.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Cloud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.